Skip to main content

Table 4 Comparison of side effects

From: Clinical analysis of 48 cases of malignant superior vena cava syndrome

 

Group 1

Group 2

Group 3

Group 4

P

Myelosuppression (%)

 I

5 (50)

4 (50)

6 (27.3)

2 (25)

0.145

 II

2 (20)

1 (12.5)

11 (50)

2 (25)

 III

0 (0)

1 (12.5)

1 (4.5)

3 (37.5)

 IV

0 (0)

1 (12.5)

1 (4.5)

0 (0)

Anemia (%)

 Mild

5 (50)

3 (37.5)

16 (72.7)

5 (62.5)

0.601

 Moderate

3 (30)

4 (50)

5 (22.7)

2 (25)

 Severe

0 (0)

0 (0)

0 (0)

1 (12.5)

Digestive tract reactions (%)

 I

0 (0)

2 (25)

6 (27.3)

3 (37.5)

0.005*

 II

0 (0)

6 (75)

11 (50)

2 (25)

Esophageal mucosal injury (%)

1 (10)

0 (0)

10 (45.5)

2 (25)

0.131

Liver function abnormality

0 (0)

1 (12.5)

10 (45.5)

2 (25)

0.389

  1. *P = 0.005 was because the radiotherapy group was included in the analysis, and pairwise comparison showed that the difference between the other three groups was not statistically significant. Group 1 radiotherapy group, Group 2 chemotherapy group, Group 3 combined radiotherapy and chemotherapy group, Group 4 comprehensive treatment group